Life Technologies | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Ardelyx USD 173.29M 14.99M 2024-12
Biogen USD 16.72B 357.1M 2024-12
Bristol-Myers Squibb USD 16.34B 807M 2024-12
Cipla INR 284.56B 0 2024-12
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 60.49M 2.15M 2024-09
CSL USD 17.36B 186M 2024-06
Galapagos EUR 2.9B 34.37M 2024-12
GlaxoSmithKline GBP 13.67B 218M 2024-12
Grifols EUR 5.88B 533.83M 2024-12
Life Technologies USD 65.32M 16.28M 2024-09
Novartis USD 44.05B 605M 2024-12
Roche Holding CHF 36.16B 3.28B 2024-12
United Therapeutics USD 6.44B 343.1M 2024-12



Life Technologies Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.